29089887|t|Cilostazol Suppresses Abeta-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway.
29089887|a|Alzheimer's disease (AD) is a slowly progressive form of dementia, characterized by memory impairment and cognitive dysfunction. AD is mainly characterized by the deposition of amyloid beta (Abeta) plaques and intracellular neurofibrillary tangles in the brain, along with neuronal degeneration and high levels of oxidative stress. Cilostazol (CSZ) was recently found to suppress the progression of cognitive decline in patients with stable AD receiving acetylcholinesterase inhibitors. This present study aimed to clarify the mechanism by which CSZ protects neurons from degeneration associated with Abeta(1-42). We used Abeta(1-42) to induce neurotoxicity in human neuroblastoma SH-SY5Y cells. Cells were pretreated with CSZ before co-treatment with Abeta. To evaluate the effect of CSZ on oxidative stress, we examined levels of reactive oxygen species (ROS), nicotinamide adenine dinucleotide phosphate oxidase (Nox) activity, mRNA expression of NOX4, and Cu/Zn-Superoxide Dismutase (SOD), as well as apoptosis biomarkers [MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), caspase-3 and -9 activities and staining of annexin V]. We also assayed the activity of mitogen-activated protein kinases (MAPK): p38 MAPK and extracellular signal-regulated kinase1/2 (ERK1/2), and biomarkers of mitochondrial function (Bcl-2 and Bax), and cyclic adenosine monophosphate response element-binding protein (CREB). Abeta-induced oxidative stress (ROS, NOX4 activity, and expression of NOX mRNA), caspase activation (caspase-3 and -9), and p38 MAPK phosphorylation were suppressed by co-treatment with CSZ, but not by ERK1/2 activation. In addition, pretreatment with CSZ suppressed Abeta-induced apoptosis and increased cell viability via suppression of Bax (a proapoptotic protein), upregulation of Bcl-2 (an antiapoptotic protein) and Cu/Zn-SOD (a superoxide scavenging enzyme), and phosphorylation of CREB. These findings suggested that CSZ could counteract neurotoxicity through multiple mechanisms, one mechanism involving the attenuation of oxidative stress by suppressing NOX activity and Nox mRNA expression in Abeta-induced neurotoxicity and another involving the anti-neurotoxic effect via the ERK1/2/phosphorylated CREB pathway.
29089887	0	10	Cilostazol	Chemical	MESH:D000077407
29089887	22	27	Abeta	Gene	351
29089887	36	49	Neurotoxicity	Disease	MESH:D020258
29089887	53	60	SH-SY5Y	CellLine	CVCL:0019
29089887	134	153	Alzheimer's disease	Disease	MESH:D000544
29089887	155	157	AD	Disease	MESH:D000544
29089887	191	199	dementia	Disease	MESH:D003704
29089887	218	235	memory impairment	Disease	MESH:D008569
29089887	240	261	cognitive dysfunction	Disease	MESH:D003072
29089887	263	265	AD	Disease	MESH:D000544
29089887	311	323	amyloid beta	Gene	351
29089887	325	330	Abeta	Gene	351
29089887	358	381	neurofibrillary tangles	Disease	MESH:D055956
29089887	407	428	neuronal degeneration	Disease	MESH:D009410
29089887	466	476	Cilostazol	Chemical	MESH:D000077407
29089887	478	481	CSZ	Chemical	MESH:D000077407
29089887	533	550	cognitive decline	Disease	MESH:D003072
29089887	554	562	patients	Species	9606
29089887	575	577	AD	Disease	MESH:D000544
29089887	680	683	CSZ	Chemical	MESH:D000077407
29089887	778	791	neurotoxicity	Disease	MESH:D020258
29089887	795	800	human	Species	9606
29089887	801	814	neuroblastoma	Disease	MESH:D009447
29089887	815	822	SH-SY5Y	CellLine	CVCL:0019
29089887	857	860	CSZ	Chemical	MESH:D000077407
29089887	886	891	Abeta	Gene	351
29089887	919	922	CSZ	Chemical	MESH:D000077407
29089887	966	989	reactive oxygen species	Chemical	MESH:D017382
29089887	991	994	ROS	Chemical	MESH:D017382
29089887	997	1048	nicotinamide adenine dinucleotide phosphate oxidase	Gene	50506
29089887	1084	1088	NOX4	Gene	50507
29089887	1094	1120	Cu/Zn-Superoxide Dismutase	Gene	6647
29089887	1122	1125	SOD	Gene	6647
29089887	1161	1164	MTT	Chemical	MESH:C070243
29089887	1167	1227	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide	Chemical	MESH:C022616
29089887	1230	1246	caspase-3 and -9	Gene	836;842
29089887	1274	1283	annexin V	Gene	308
29089887	1373	1413	extracellular signal-regulated kinase1/2	Gene	5594
29089887	1415	1421	ERK1/2	Gene	5595;5594
29089887	1466	1471	Bcl-2	Gene	596
29089887	1476	1479	Bax	Gene	581
29089887	1551	1555	CREB	Gene	1385
29089887	1558	1563	Abeta	Gene	351
29089887	1590	1593	ROS	Chemical	MESH:D017382
29089887	1595	1599	NOX4	Gene	50507
29089887	1659	1675	caspase-3 and -9	Gene	836;842
29089887	1744	1747	CSZ	Chemical	MESH:D000077407
29089887	1760	1766	ERK1/2	Gene	5595;5594
29089887	1810	1813	CSZ	Chemical	MESH:D000077407
29089887	1825	1830	Abeta	Gene	351
29089887	1897	1900	Bax	Gene	581
29089887	1943	1948	Bcl-2	Gene	596
29089887	1993	2003	superoxide	Chemical	MESH:D013481
29089887	2047	2051	CREB	Gene	1385
29089887	2083	2086	CSZ	Chemical	MESH:D000077407
29089887	2104	2117	neurotoxicity	Disease	MESH:D020258
29089887	2262	2267	Abeta	Gene	351
29089887	2276	2289	neurotoxicity	Disease	MESH:D020258
29089887	2321	2331	neurotoxic	Disease	MESH:D020258
29089887	2347	2353	ERK1/2	Gene	5595;5594
29089887	2369	2373	CREB	Gene	1385
29089887	Negative_Correlation	MESH:D000077407	836
29089887	Negative_Correlation	MESH:D000077407	50507
29089887	Negative_Correlation	MESH:D000077407	MESH:D000544
29089887	Association	351	596
29089887	Positive_Correlation	MESH:D000077407	596
29089887	Association	351	836
29089887	Negative_Correlation	MESH:D000077407	581
29089887	Negative_Correlation	MESH:D000077407	MESH:D003072
29089887	Association	MESH:D000077407	6647
29089887	Positive_Correlation	351	50507
29089887	Negative_Correlation	MESH:D000077407	842
29089887	Negative_Correlation	MESH:D000077407	MESH:D020258
29089887	Positive_Correlation	MESH:D020258	351
29089887	Negative_Correlation	MESH:D000077407	MESH:D017382
29089887	Association	351	842
29089887	Negative_Correlation	MESH:D000077407	351
29089887	Association	MESH:D000544	351
29089887	Positive_Correlation	MESH:D017382	351
29089887	Association	MESH:D000077407	MESH:D013481
29089887	Association	MESH:D013481	351

